T. Rowe Price's top September ETF returns drew little cash; core funds led flows
The Active Crypto ETF returned 8.7% and the Technology ETF 8%, but the Capital Appreciation Equity ETF took $647.47 million of the lineup's $1.41 billion in September inflows.
T. Rowe Price's lineup of 39 active ETFs gathered roughly $1.41 billion in September, and nearly half of it went to a single fund: the Capital Appreciation Equity ETF took $647.47 million, according to ETF Database figures reported by ETF Trends, with the Ultra Short-Term Bond ETF adding $171.61 million and the Small-Mid Cap ETF $135.36 million. Three funds out of 39 accounted for about $954 million, or roughly two-thirds of the month's intake, a concentration worth pausing over in a book whose largest fund, TCAF at $8.6 billion, is a core equity strategy.
The performance table ran the other way, with the Active Crypto ETF (TKNZ) posting the lineup's best September return at 8.7%, followed by the Technology ETF (TTEQ) at 8% and the Growth Stock ETF (TGRW) at 2.7%, on the same ETF Database data. TKNZ launched July 15, holds about $25.3 million, keeps bitcoin and ether at roughly 56% of assets as of October 2, and charges 0.75%; TTEQ, up just over 38% this year, held chipmakers at 61.2% of the portfolio as of June 30 and charges 0.63%; TGRW charges 0.52%.
TCAF at 0.31% takes nearly half the money
Strip TCAF from the lineup and the other 38 funds average well under $1 billion apiece; the flagship's $8.6 billion is about a quarter of the $34.3 billion total, and September did nothing to flatten the spread. It took nearly half the month's money, and the three funds that split about $954 million left the other 36 to divide the remaining third.
The wrapper has largely stopped being the product at T. Rowe Price: as this publication has argued, the active ETF wrapper has become a fee and distribution tool more than a product identity, and this lineup is a clean exhibit of the shift. On these numbers the firm does not need the crypto fund or the tech fund to gather assets for the franchise to work; it needs TCAF to keep doing what an $8.6 billion core equity fund does at 0.31%. The specialized funds, on September's evidence, exist mainly to post the returns that put the lineup into performance tables.
The $171.61 million that found TBUX is the one flow of the month that doubles as a category trade. Ultrashort bond ETFs run on a spread that rates will test, and money reaching for 4.37% paid monthly at a 0.17% fee is making that trade about as directly as it can be made. T. Rowe Price's version arrives with the firm's credit desk behind it, which is the only thing that distinguishes it from the queue of ultrashort products chasing the same spread.
A crypto fund at the top of a $34.3 billion book
TTEQ's 8% September and 38% year-to-date gain land on a question raised in September: whether a mandate built on a definition index funds cannot use holds up when technology leadership narrows. Chipmakers at 61.2% of the portfolio as of June 30 make the fund's return and its concentration the same fact, and the year-to-date figure is the argument for the 0.63% fee.
TKNZ is harder to read, because a portfolio of five to 15 crypto assets that launched in mid-July has less than a quarter of performance history. The 8.7% month is real, and so is bitcoin and ether making up about 56% of a $25.3 million fund; what September cannot show is whether the return came from the manager's selection among those assets or from the assets themselves, and at that size the distinction is nearly academic.
One month of flows is a statement about investor timing as much as about any fund, and September was a single month. TCAF's $8.6 billion and nearly half the month's money make the flagship most of the lineup's business, while the crypto fund that led the return table holds $25.3 million inside the same $34.3 billion book. Whether TKNZ gathers assets on the strength of an 8.7% third month, or stays a small line beside a core equity fund that dwarfs it, is what the next few monthly tapes will show.
Save this analysis and keep the funds you follow together in My Desk.
Sign in to save articles or follow funds.